Építés alatt – nem éles oldal
Belépés
LeállítvaKorai 1. fázis

Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice

A legfontosabb adatok

Ki végzi
Joshua A. Lile, Ph.D.
Hol
Lexington (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Leállítva
Fázis
Korai 1. fázis
Résztvevők
2 fő vett részt
Kezdés
2023. márc. 1.
Befejezés
2025. márc. 28.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Drug Cue
  • Money
  • Withdrawal
  • Remifentanil
A regiszteradat frissítve
2026. március 30.
Miért állt le
Funding ended

Ki vehet részt

Életkor
18 év – 50 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 15 feltétel megnézéseKevesebb

Ki vehet részt

  • Individuals must meet criteria for moderate/severe opioid use disorder, report past month opioid misuse, and be physically dependent on short-acting opioids (e.g., heroin, hydromorphone, fentanyl), as evidenced by either urine sample positive for recent opioid use during each visit or if opioid negative, displaying frank withdrawal during screening
  • History of intravenous opioid use
  • Baseline O2 saturation of 95% or greater
  • Between the ages of 18-50 years
  • Female subjects must be using an effective form of birth control (e.g., birth control pills, surgical sterilization, IUD, cervical cap with a spermicide, or abstinence). Urine pregnancy tests will be conducted prior to sessions to ensure that female subjects do not participate if pregnant
  • Able to speak and read English
  • Otherwise healthy

Ki nem vehet részt

  • Contraindications for MRI scanning (e.g., pacemaker, metal implants, claustrophobia, or any other implanted medical device)
  • Regular use of other medications, with the exception of hormone-based contraceptives for female subjects, daily multivitamins or short-term antibiotic prescriptions
  • Seeking treatment for SUD or currently taking buprenorphine or methadone as the primary opioid of use
  • History of, or current, clinically significant physical disease (e.g., respiratory disease [asthma, COPD, sleep apnea], impaired cardiovascular functioning, seizure disorder or CNS tumors) or current or past history of psychiatric disorder that would limit compliance in the studies, other than substance use disorder
  • Meet diagnostic criteria for psychoactive substance use disorder for substances other than opioids (OUD subjects only) or nicotine/caffeine that would require detoxification (i.e., alcohol, benzodiazepines or barbiturates). Negative urine/breath samples for these substances, and the absence of withdrawal, will be required during screening
  • Vision or hearing problems that would preclude completion of experimental tasks
  • Poor venous access
  • At risk for respiratory complications and have predictors of difficult bag mask ventilation (e.g., dentures, very full beard), in case emergency respiratory intervention is needed

Helyszínek itt: Egyesült Államok

  • University of KentuckyLexington, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The objective of this protocol is to use probabilistic choice tasks to determine the impact of withdrawal and drug cues on decision-making in individuals with opioid use disorder and physical opioid dependence.

A vizsgálat csoportja

  • Probabilistic Choice TaskA vizsgált kezelés

    Subjects with opioid use disorder complete a probabilistic concurrent choice task under opioid maintained and withdrawn conditions. Three sessions include a money-vs-money task and three sessions include a drug-vs-money task. Monetary reward value is $0.25 or $4.00. Task option visual cues for the money-vs-money versions are colored envelopes or opioid-associated and matched neutral cues. Drug is an active dose of remifentanil.

    Kezelés: Drug Cue, Money, Withdrawal és Remifentanil

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Behavioral Effects of Drugs Inpatient 44: Neurobehavioral Mechanisms of Opioid Choice
A regiszteradat frissítve
2026. március 30.